Replimune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.

CEO

Sushil Patel

CEOSushil Patel

Employees

479

Employees479

Headquarters

Woburn, Massachusetts

HeadquartersWoburn, Massachusetts

Founded

2015

Founded2015

Employees

479

Employees479

REPL Key Statistics

Market cap

714.59M

Market cap714.59M

Price-Earnings ratio

-2.89

Price-Earnings ratio-2.89

Dividend yield

—

Dividend yield—

Average volume

1.03M

Average volume1.03M

High today

$9.64

High today$9.64

Low today

$9.17

Low today$9.17

Open price

$9.60

Open price$9.60

Volume

1.47M

Volume1.47M

52 Week high

$17.00

52 Week high$17.00

52 Week low

$6.44

52 Week low$6.44

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.

Recursion Pharmaceuticals

Replimune

Why Robinhood?

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. Show more

REPL Key Statistics

Analyst ratings

100%

People also own

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.